Brief: Eliem Therapeutics Reports First Quarter Financial Results

Climb Bio

11/05/2023 21:25

May 11 (Reuters) - Eliem Therapeutics Inc  ELYM.O :
    * ELIEM THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS
AND
BUSINESS HIGHLIGHTS
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WAS
$109.4
MILLION AS OF MARCH 31, 2023
    * CO'S CURRENT CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES
ARE EXPECTED TO FUND OPERATIONS INTO 2027
    * QTRLY LOSS PER SHARE $0.84
    * Q1 EARNINGS PER SHARE VIEW $-0.25 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX62mlrn 
Further company coverage:  ELYM.O 

 ((Reuters.Briefs@thomsonreuters.com;))